Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment
Acta Neuropathologica · 22.07.2024 · 148 (1)
DOI: 10.1007/s00401-024-02767-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Neuropathologica, online erschienen am 22.07.2024. Verfasst von Dominique Leitner und 10 weiteren Autor:innen. Beteiligte Einrichtung: Center for Cognitive Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA. Hauptthemen laut MEDLINE: Cerebral Amyloid Angiopathy, Alzheimer Disease, Cognitive Dysfunction, Proteome. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIA.
Themen: Demenz
Abstract (Originalsprache)
Cerebral amyloid angiopathy (CAA) is characterized by amyloid beta (Aβ) deposition in cerebrovasculature. It is prevalent with aging and Alzheimer’s disease (AD), associated with intracerebral hemorrhage, and contributes to cognitive deficits. To better understand molecular mechanisms, CAA(+) and CAA(−) vessels were microdissected from paraffin-embedded autopsy temporal cortex of age-matched Control ( n = 10), mild cognitive impairment (MCI; n = 4), and sporadic AD ( n = 6) cases, followed by label-free quantitative mass spectrometry. 257 proteins were differentially abundant in CAA(+) vessels compared to neighboring CAA(−) vessels in MCI, and 289 in AD ( p < 0.05, fold-change > 1.5). 84 proteins changed in the same direction in both groups, and many changed in the same direction among proteins significant in at least one group ( p < 0.0001, R 2 = 0.62). In CAA(+) vessels, proteins significantly increased in both AD and MCI were particularly associated with collagen-containing extracellular matrix, while proteins associated with ribonucleoprotein complex were significantly decreased in both AD and MCI. In neighboring CAA(−) vessels, 61 proteins were differentially abundant in MCI, and 112 in AD when compared to Control cases. Increased proteins in CAA(−) vessels were associated with extracellular matrix, external encapsulating structure, and collagen-containing extracellular matrix in MCI; collagen trimer in AD. Twenty two proteins were increased in CAA(−) vessels of both AD and MCI. Comparison of the CAA proteome with published amyloid-plaque proteomic datasets identified many proteins similarly enriched in CAA and plaques, as well as a protein subset hypothesized as preferentially enriched in CAA when compared to plaques. SEMA3G emerged as a CAA specific marker, validated immunohistochemically and with correlation to pathology levels ( p < 0.0001; R 2 = 0.90). Overall, the CAA(−) vessel proteomes indicated changes in vessel integrity in AD and MCI in the absence of Aβ, and the CAA(+) vessel proteome was similar in MCI and AD, which was associated with vascular matrix reorganization, protein translation deficits, and blood brain barrier breakdown.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Cognitive Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA.
- Comprehensive Epilepsy Center, New York University Grossman School of Medicine, New York, NY, 10016, USA.
- Department of Neurology, New York University Grossman School of Medicine, New York, NY, 10016, USA.
- Brain and Mind Centre and School of Medical Sciences, University of Sydney, Camperdown, NSW, 2050, Australia.
- Proteomics Laboratory, Division of Advanced Research Technologies and Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, 10016, USA.
- Department of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, NY, 10016, USA.
ORCID-Profile: Thomas Wisniewski
Förderung
- NIA NIH HHS
- NIA
Zitieren
APA
Leitner, D., Kavanagh, T., Kanshin, E., Balcomb, K., Pires, G., Thierry, M., Suazo, J. I., Schneider, J., Ueberheide, B., Drummond, E., & Wisniewski, T. (2024). Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment. Acta Neuropathologica, 148(1). https://doi.org/10.1007/s00401-024-02767-1
Vancouver
Leitner D, Kavanagh T, Kanshin E, Balcomb K, Pires G, Thierry M, et al. Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment. Acta Neuropathologica. 2024;148(1). doi:10.1007/s00401-024-02767-1
BibTeX
@article{Leitner2024,
author = {Leitner, Dominique and Kavanagh, Tomas and Kanshin, Evgeny and Balcomb, Kaleah and Pires, Geoffrey and Thierry, Manon and Suazo, Jianina I and Schneider, Julie and Ueberheide, Beatrix and Drummond, Eleanor and Wisniewski, Thomas},
title = {Differences in the cerebral amyloid angiopathy proteome in Alzheimer’s disease and mild cognitive impairment},
journal = {Acta Neuropathologica},
year = {2024},
volume = {148},
number = {1},
doi = {10.1007/s00401-024-02767-1}
}
EUVIMED